Fanconi syndrome following administration of oral supplements containing red yeast rice: several months follow-up of three cases
CEN Case Reports · 2024
DOI: 10.1007/s13730-024-00955-2 ↗Kurz gefasst
Fallbericht in der Zeitschrift CEN Case Reports, 2024. Verfasst von Reina Matsui-Hosoya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima-ku, Tokyo, 177-8521, Japan. Hauptthemen laut MEDLINE: Fanconi Syndrome, Dietary Supplements, Acute Kidney Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To date, the treatment strategy and long-term prognosis of acute kidney injury (AKI) after taking Benikoji CholesteHelp ® , a red yeast rice supplement, remains unclear. We present three cases wherein renal dysfunction improved within a few months of supplement discontinuation, without immunosuppressive therapy. Case 1: A 59-year-old woman with a history of hypertension, treated with telmisartan (serum creatinine [sCr]: 0.65 mg/dL; estimated glomerular filtration rate [eGFR]: 71.3 mL/min/1.73 m 2 ) and Benikoji CholesteHelp ® for 7 months, developed Fanconi syndrome (FS) and severe renal impairment (sCr: 2.32 mg/dL; eGFR: 17.7 mL/min/1.73 m 2 ). Renal biopsy and gallium-67 scintigraphy revealed no active drug-induced interstitial nephritis. Her condition improved significantly after supplement discontinuation. Her renal function gradually improved, with 3-month follow-up sCr and eGFR values of 0.96 mg/dL and 46.5 mL/min/1.73 m 2 , respectively; however, these were still worse than the pre-onset values. Case 2: A 48-year-old man had mild renal dysfunction (sCr: 1.12 mg/dL; eGFR: 56.76 mL/min/1.73 m 2 ) after taking Benikoji CholesteHelp ® for approximately 2 years; this was reversed upon supplement discontinuation. Case 3: A 47-year-old man with FS and mild renal dysfunction (sCr: 1.09 mg/dL; eGFR: 58.5 mL/min/1.73 m 2 ) after taking Benikoji CholesteHelp ® for approximately 4 months, showed notable improvement in FS after supplement discontinuation; however, the mild renal dysfunction persisted. The primary intervention in all cases was immediate supplement discontinuation, leading to rapid improvement in renal function, without need for immunosuppressive therapy. These findings increase our understanding of renal impairment caused by red yeast rice, with improvement after withdrawal, sometimes after several months.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima-ku, Tokyo, 177-8521, Japan.
- Department of Nephrology, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima-ku, Tokyo, 177-8521, Japan. hiroaki@juntendo.ac.jp.
- Department of Nephrology, Faculty of Medicine, Juntendo University, 3-1-3 Hongou, Bunkyo-ku, Tokyo, 133-8431, Japan.
ORCID-Profile: Hiroaki Io
Zitieren
APA
Matsui-Hosoya, R., Sato, K., Yagasaki, M., Hirose, H., Fukao, Y., Kano, T., Io, H., & Suzuki, Y. (2024). Fanconi syndrome following administration of oral supplements containing red yeast rice: several months follow-up of three cases. CEN Case Reports. https://doi.org/10.1007/s13730-024-00955-2
Vancouver
Matsui-Hosoya R, Sato K, Yagasaki M, Hirose H, Fukao Y, Kano T, et al. Fanconi syndrome following administration of oral supplements containing red yeast rice: several months follow-up of three cases. CEN Case Reports. 2024. doi:10.1007/s13730-024-00955-2
BibTeX
@article{MatsuiHosoya2024,
author = {Matsui-Hosoya, Reina and Sato, Koji and Yagasaki, Motohiro and Hirose, Hitomi and Fukao, Yusuke and Kano, Toshiki and Io, Hiroaki and Suzuki, Yusuke},
title = {Fanconi syndrome following administration of oral supplements containing red yeast rice: several months follow-up of three cases},
journal = {CEN Case Reports},
year = {2024},
doi = {10.1007/s13730-024-00955-2}
}
EUVIMED